文献速递脊柱关节炎

脊柱关节炎外周关节炎评估工具的效度评价:ASAS-PerSpA研究分析

Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study.
PubMed 文献 · Ann Rheum Dis · 2025-03-17

基于ASAS-PerSpA研究4121例中轴型脊柱关节炎、外周型脊柱关节炎或银屑病关节炎患者,评估多种疾病活动度工具的结构效度,包括与外部构念的相关性和已知组判别。所有工具与外部构念的相关性假设100%确认,除C反应蛋白外所有工具的标准均数差≥0.8,DAS28判别力最高,其次为DAPSA。

要点

  • 所有评估外周关节炎的疾病活动度工具与外部构念的相关性均表现优秀,100%假设得到确认。
  • 除C反应蛋白外,所有疾病活动度指标的标准均数差≥0.8,判别力良好。
  • 在区分活动性与非活动性疾病时,包含关节计数的复合评分(如DAS28和DAPSA)判别力最高。

核心结论

  • 所有评估外周关节炎的疾病活动度工具在结构效度分析中表现良好,体现在与外部构念的相关性和已知组判别上。
  • 区分活动性与非活动性疾病时,包含关节计数的复合评分(如DAS28和DAPSA)判别能力最高。

研究设计与样本

  • 本研究为ASAS-PerSpA研究的一项分析,纳入诊断为中轴型脊柱关节炎、外周型脊柱关节炎或银屑病关节炎的患者。
  • 评估的工具包括患者总体评估、Bath强直性脊柱炎疾病活动指数、中轴型脊柱关节炎疾病活动度评分、银屑病关节炎疾病活动指数(DAPSA)、肿胀关节计数、压痛关节计数、疾病活动度评分(DAS)28、DAS44和C反应蛋白。
  • 结构效度通过与外构念(Bath强直性脊柱炎功能指数、ASAS健康指数和欧洲五维健康量表)的相关性以及已知组判别(基于患者总体评估≥5/<5与肿胀关节计数≥1/0和≥2/<2组合定义活动性/非活动性疾病)采用标准化均数差(SMD)进行分析。

主要发现

  • 共纳入4121例患者,平均年龄45岁(标准差14),男性占61%。
  • 通过与外构念的相关性评估结构效度时,所有工具表现优秀(100%假设确认)。
  • 评估已知组判别时,除C反应蛋白外,所有疾病活动度指标的标准均数差≥0.8(判别力良好),其中DAS28的标准均数差最高,其次为DAPSA。
  • 在不同疾病表型中结果相似。
  • 综合考虑患者总体评估和肿胀关节计数的所有组合来区分活动性/非活动性疾病时,包含关节计数的复合评分表现更好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess construct validity, including known-group discrimination, of the currently available disease activity instruments assessing peripheral arthritis in spondyloarthritis (SpA). METHODS: In this analysis from the Assessment of SpondyloArthritis International Society (ASAS)-PerSpA study, patients with a diagnosis of axial SpA, peripheral SpA, or psoriatic arthritis (PsA) were included. The disease activity instruments evaluated were the Patient Global Assessment (PGA), Bath Ankylosing Spondylitis Disease Activity Index, Axial Spondyloarthritis Disease Activity Score, Disease Activity Index for PsA (DAPSA), Swollen Joint Count (SJC), Tender Joint Count, Disease Activity Score (DAS) 28, DAS44, and C-reactive protein (CRP). Construct validity was assessed through correlations with external constructs (Bath Ankylosing Spondylitis Functional Index, ASAS Health Index, and Euro Quality of Life 5 Dimensions) and known-group discrimination (active/inactive disease based on a combination of PGA [≥5/<5]), and SJC (≥1/0 and ≥2/<2) was analysed using standardised mean differences (SMDs). RESULTS: In total, 4121 patients were included (mean age 45 [SD, 14] years, 61% males). When assessing the construct validity through correlations with external constructs, all instruments performed excellently (100% hypotheses confirmed). When assessing known-group discrimination, all disease activity measures, except CRP, presented SMDs ≥ 0.8 (good discrimination), with higher SMDs observed for DAS28 followed by DAPSA. Results were similar across disease phenotypes. Considering all combinations of PGA and SJC to discriminate between active/inactive disease, a better performance was observed for the composite scores, including joint counts. CONCLUSIONS: In our construct validity analysis, all disease activity instruments assessing peripheral arthritis had a good performance as reflected in the correlations with external constructs and the known-group discrimination. The highest discriminatory capacity to distinguish between 'active/inactive disease' was observed for composite scores, including joint counts, like DAS28 and DAPSA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Capelusnik D, Lopez-Medina C, van der Heijde D, et al. Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study. Ann Rheum Dis. 2025. PMID: 40102118. doi:10.1016/j.ard.2025.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。